1. Home
  2. ALMR vs XXI Comparison

ALMR vs XXI Comparison

Compare ALMR & XXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alamar Biosciences Inc. Common Stock

ALMR

Alamar Biosciences Inc. Common Stock

N/A

Current Price

$28.64

Market Cap

2.1B

Sector

Industrials

ML Signal

N/A

Logo Twenty One Capital Inc. Class A Common Stock

XXI

Twenty One Capital Inc. Class A Common Stock

N/A

Current Price

$4.31

Market Cap

1.9B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ALMR
XXI
Founded
2018
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Finance: Consumer Services
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2026
2026

Fundamental Metrics

Financial Performance
Metric
ALMR
XXI
Price
$28.64
$4.31
Analyst Decision
Buy
Analyst Count
5
0
Target Price
★ $37.00
N/A
AVG Volume (30 Days)
674.6K
★ 1.3M
Earning Date
11-03-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$64.80
N/A
Revenue Next Year
$37.27
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.58
$4.15
52 Week High
$39.61
$11.49

Technical Indicators

Market Signals
Indicator
ALMR
XXI
Relative Strength Index (RSI) 45.59 26.91
Support Level $23.87 $4.15
Resistance Level $29.06 $5.71
Average True Range (ATR) 2.38 0.31
MACD -0.06 -0.11
Stochastic Oscillator 47.77 3.68

Price Performance

Historical Comparison
ALMR
XXI

About ALMR Alamar Biosciences Inc. Common Stock

Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.

About XXI Twenty One Capital Inc. Class A Common Stock

Twenty One Capital Inc is engaged in the Bitcoin-related business lines. It engages in two principal activities: actively accumulating Bitcoin and managing its Bitcoin holdings, and commencing development of educational materials and branded content intended to drive increased institutional and retail investor Bitcoin literacy.

Share on Social Networks: